O-2372

O-2372
Identifiers
	IUPAC name 6-((6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl)-6-methyl-1-morpholinoheptan-1-one;
CAS Number	874631-37-5 ;
PubChem CID	24848987;
ChemSpider	21259336 ;
UNII	26A5UES5ZR;
CompTox Dashboard (EPA)	DTXSID901029739 ;
Chemical and physical data
Formula	C28H41NO4
Molar mass	455.639 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1(C)[C@H]2[C@@H](CC(C)=CC2)C3=C(C=C(C(C)(C)CCCCC(N4CCOCC4)=O)C=C3O)O1;
	InChI InChI=1S/C28H41NO4/c1-19-9-10-22-21(16-19)26-23(30)17-20(18-24(26)33-28(22,4)5)27(2,3)11-7-6-8-25(31)29-12-14-32-15-13-29/h9,17-18,21-22,30H,6-8,10-16H2,1-5H3/t21-,22-/m1/s1 ; Key:ASKNFEPPYVJXIA-FGZHOGPDSA-N ;
	(what is this?) (verify)

O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB₁ and CB₂ receptors, with K_i values of 1.3 nM at CB₁ and 0.57 nM at CB₂, but is only moderately soluble in water compared to other related compounds such as O-2694, which it is a metabolite of.^[1]

References

^ Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK (September 2006). "Pharmacological characterization of novel water-soluble cannabinoids". The Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1230–9. doi:10.1124/jpet.106.104109. PMID 16757541. S2CID 14864925.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[pmid16757541-1] Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK (September 2006). "Pharmacological characterization of novel water-soluble cannabinoids". The Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1230–9. doi:10.1124/jpet.106.104109. PMID 16757541. S2CID 14864925.

[1]

See also

References